Product Labelling. (a) During the Exclusive Period, the Labelling shall, if Schering elects to use the ICN Trademark, contain the ICN Trademark and shall otherwise be consistent in format (but not substance) with the Labelling for Schering's other pharmaceutical products sold in the corresponding country within the Territory at the time in question. Unless prohibited by applicable law, if Schering elects to use the ICN Trademark, the Labelling shall indicate that the Product is under license from ICN.
Appears in 7 contracts
Samples: Stock Purchase Agreement (Icn Pharmaceuticals Inc), Exclusive License and Supply Agreement (Icn Pharmaceuticals Inc), Stock Purchase Agreement (Icn Pharmaceuticals Inc)
